CLINICAL COLLECTION AND USE OF PERIPHERAL BLOOD STEM CELLS IN PEDIATRIC PATIENTS

Larry C. Lasky(Cleveland State University), Norma K.C. Ramsay(University of Minnesota), Bruce Bostrom(Minnesota West Community & Technical College), Thomas J. Moss(Neostem (United States)), Judith A. Smith(University of Wisconsin–Madison)

Transplantation

April 1, 1989

10.1097/00007890-198904000-00010

Cited by 69

Related Papers

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

|Blood|2007|536

A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study

|Blood|2002|496

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

|Blood|2003|361

Comparison of Autologous and Allogeneic Bone Marrow Transplantation for Treatment of High-Risk Refractory Acute Lymphoblastic Leukemia

|New England Journal of Medicine|1987|334

Juvenile xanthogranuloma: Forms of systemic disease and their clinical implications

|The Journal of Pediatrics|1996|294